Results 81 to 90 of about 2,119 (113)

Early Erythroblastic Leukemia Presenting asDe NovoAcute Leukemia

Leukemia & Lymphoma, 1990
Early erythroblastic leukemia is a newly defined type of leukemia in which the blasts have the same characteristics as erythroid precursors at the level of CFU-E. The blasts are characterized by the presence of carbonic anhydrase I, CD 36 antigen, platelet peroxidase (PPO)-like activity, and ferritin-containing granules.
T, Koike, E, Takakuwa, A, Shibata
openaire   +2 more sources

Acute erythroblastic leukemia presenting as acute undifferentiated leukemia: A report of two cases with ultrastructural features

Leukemia Research, 1985
This report describes two elderly patients with acute leukemia in which blast cells were undifferentiated with conventional light microscopy (L.M.) and cytochemistry. Blast cells were identified as belonging to the erythroblastic line by their ultrastructural features: glycogen deposits, lipidic vacuoles, cytoplasmic ferritin molecules and ...
J, Reiffers, P, Bernard, J, Larrue, D, Dachary, B, David, M, Boisseau, A, Broustet   +6 more
openaire   +2 more sources

Erythroblast predominance without CD41/cyCD41-positive blasts predicts favorable prognosis in patients with myelodysplastic syndromes and acute myeloid leukemias treated with azacitidine

International Journal of Hematology, 2022
This study examined the prognostic impact of erythroblast predominance (EP) in 61 patients with myelodysplastic syndromes (MDS) (n = 51) or acute myeloid leukemia (n = 10) treated with azacitidine. Median age was 78 years. EP, defined as > 40% erythroblasts and M/E 
Akihito Matsuoka, Masaki Tanibuchi, Ieharu Yamazaki, Teruhisa Taoka   +3 more
openaire   +2 more sources

Derivative (1;7)(q10;p10) in a Patient with de novo Acute Erythroblastic Leukemia (AML-M6)

Cancer Genetics and Cytogenetics, 1999
A rare association of der(1;7)(q10;p10) with de novo acute erythroblastic leukemia (AML-M6) in a 63-year-old male is reported. While this unbalanced 1;7 translocation, der(1;7), has been reported often in therapy-related myelodysplastic syndrome (t-MDS) or therapy-related acute myeloid leukemia (t-AML), its associations with de novo AML-FAB-M6 have ...
N, Obara, A, Shinagawa, T, Komatsu, T, Abe, H, Ninomiya   +4 more
openaire   +2 more sources

Distinctive Multidrug Sensitivity and Outcome of Acute Erythroblastic and Megakaryoblastic Leukemia in Children With Down Syndrome

International Journal of Hematology, 2001
We assessed the in vitro chemosensitivity of acute erythroblastic and megakaryoblastic leukemia cells from children with Down syndrome (DS) compared to non-DS children. We conducted in vitro tests using the MTT assay of bone marrow samples from 12 children with DS and 16 children without DS.
S, Yamada, T, Hongo, S, Okada, C, Watanabe, Y, Fujii, H, Hori, M, Yazaki, R, Hanada, Y, Horikoshi   +8 more
openaire   +2 more sources

Acute Erythroblastic Leukemia is a Rare, but Distinct Subtytpe of Acute Myeloid Leukemia

1998
We described four cases of de novo acute leukemia, which were initially diagnosed as undifferentiated leukemia or AML-MO because of negative myeloperoxidase (MPO) activity, absence of B/T lymphoid markers and positive myeloid markers (CD 13 and/or CD33).
M. Saito, K. Kuriyama, H. Tsusima, Y. Miyazaki, M. Tomonaga   +4 more
openaire   +1 more source

Micronuclei and Nuclear Abnormalities Observed in Erythroblasts in Myelodysplastic Syndromes and in de novo Acute Leukemia after Treatment

Acta Haematologica, 1999
The frequencies of erythroblasts with micronuclei (EBM) and erythroblasts with aberrant nuclear shapes (EBAN) in bone marrow were evaluated in 60 patients with untreated myelodysplastic syndrome (MDS), and also in 21 patients with acute leukemia before and after treatment, and the results were compared regarding cytogenetic patterns.
H, Yashige, S, Horiike, M, Taniwaki, S, Misawa, T, Abe   +4 more
openaire   +2 more sources

Unusually Long Survival of a 67-Year-Old Patient with Near-Tetraploid Acute Myeloid Leukemia M0 without Erythroblastic and Megakaryocytic Dysplasia

Acta Haematologica, 2011
Patients with near-tetraploid acute myeloid leukemia (NT-AML) typically have poor survival. We present the case of a 67-year-old Caucasian male with NT-AML M0 who had an unusually long first complete remission of 51 months and an overall survival of 80 months.
Petr, Lemež, Hana, Klamová, Zuzana, Zemanová, Iuri, Marinov, Ota, Fuchs, Jiří, Schwarz, Jana, Březinová, Dana, Provazníková, Arnošt, Kostečka, Jana, Marková, Kyra, Michalová, Jaroslav, Jelínek   +11 more
openaire   +2 more sources